Entering text into the input field will update the search result below

AcelRx announces date of FDA advisory committee meeting for DSUVIA

  • AcelRx Pharmaceuticals (NASDAQ:ACRX) announces that the Anesthetic and Analgesic Drug Products Advisory Committee of the FDA has planned an Advisory Committee meeting to review the Company's NDA for DSUVIA for the management of moderate-to-severe acute pain in medically supervised settings in adult patients.
  • The FDA accepted AcelRx's NDA in May. The target action date is November 3.

Recommended For You

About TLPH Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
TLPH--
Talphera, Inc.